The Good
Pricing is very competitive, little protocol optimization was required
The Bad
This product seemed to have high background signal compared to other CD11b antibodies we have used.
The Bottom Line
Very competitively priced CD11b antibody. This seems like it may have higher background than others, but we were still able to get results consistent with other CD11b antibodies we have used (such as those from BD) by percent change in expression without optimization of our staining protocol. It is possible that background could be minimized with further optimization if looking for small changes in protein expression.